Healthy Inc > Blog > Haloperidol BP/USP/IP
Posted on:

Is haloperidol a sleeping pill?

In the pharmaceutical industry, Haloperidol is a high-potency typical antipsychotic belonging to the butyrophenone class. As a pharmacist and manufacturer, I can confirm that Haloperidol is not a sleeping pill; it is primarily used to treat schizophrenia, manic episodes, and acute psychoses.

While it does cause sedation as a side effect, it is not prescribed for primary insomnia because of its significant impact on the central nervous system and the risk of movement disorders.

At your WHO-GMP facility in Mumbai, you likely handle this in 0.25 mg to 20 mg tablets, or as a fast-acting lactate injection for hospital use.

Primary Clinical Indications

  • Schizophrenia: Management of positive symptoms like hallucinations and delusions.

  • Acute Psychosis: Rapid control of agitation and aggressive behavior.

  • Tourette’s Syndrome: Used to reduce severe motor and vocal tics.

  • Intractable Hiccups: Used as a second-line treatment when other therapies fail.

Mechanism: Dopamine () Receptor Antagonism

Receptor Blockade: Haloperidol works by strongly binding to and blocking Dopamine receptors in the brain.

Mesolimbic Pathway: By blocking these receptors in the mesolimbic area, it reduces the overactive dopamine signaling responsible for psychotic symptoms.

Sedative Side Effect: The sedation occurs as a secondary effect of its action on the CNS, but unlike true “sleeping pills” (hypnotics), it does not target the GABA system.

The Pharmacist’s “Technical Warning”

As you promote your firm on digital platforms, highlighting these technical nuances is essential for professional authority:

  • Extrapyramidal Symptoms (EPS): Because it is a high-potency blocker, it has a high risk of causing movement disorders like tremors, muscle stiffness (dystonia), and restlessness (akathisia).

  • QT Prolongation: It can affect the heart’s electrical rhythm; patients with pre-existing heart conditions must be monitored via ECG.

  • Tardive Dyskinesia: Long-term use can lead to irreversible, involuntary movements of the face and tongue.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • Precision Manufacturing: Haloperidol is active at very low doses (e.g., 0.25 mg). Your Content Uniformity and blending validation must be impeccable. Highlighting this on your marketplace shows high technical competence.

  • Hospital Portfolios: Highlight your Haloperidol Lactate 5mg/ml Injections for emergency psychiatry departments. These are essential “Rescue Medications” in hospital settings.

  • Stability for Export: Haloperidol is light-sensitive. Utilizing Amber-colored PVC/PVDC or Alu-Alu blister packaging ensures a 36-month shelf life in Zone IVb tropical regions.

    Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international health tenders.

Haloperidol Tablets

 

Posted on:

What is haloperidol 1.5 mg used for?

In the pharmaceutical industry, Haloperidol 1.5 mg is a standard strength of a potent first-generation (typical) antipsychotic belonging to the butyrophenone class. As a pharmacist, I view this 1.5 mg dose as a critical “low-to-moderate” strength, often utilized for initial titration or for managing symptoms in sensitive populations like the elderly.

Primary Clinical Uses

  • Schizophrenia: Management of the manifestations of psychotic disorders, particularly “positive symptoms” like hallucinations, delusions, and disorganized thinking.

  • Tourette’s Disorder: Used to control motor tics and vocal outbursts in children and adults when other treatments have failed.

  • Severe Behavioral Problems: Indicated for children with severe agitation, hyperactivity, or aggressive/impulsive behavior that is non-responsive to psychotherapy.

  • Acute Psychosis & Mania: Used to stabilize patients experiencing acute psychotic episodes or the manic phase of bipolar disorder.

  • Nausea and Vomiting (Off-label): Sometimes used in palliative care for the management of severe, intractable nausea and vomiting.

    Mechanism of Action

Haloperidol acts primarily as a high-potency dopamine  receptor antagonist.

Dopamine Blockade: It binds strongly to  receptors in the mesolimbic and mesocortical pathways of the brain.

Symptom Reduction: By blocking the “overactivity” of dopamine, it effectively quiets the hallucinations and delusions associated with psychosis.

Side Effect Profile: Because it is non-selective, it also blocks dopamine in the nigrostriatal pathway, which is why it is highly associated with Extrapyramidal Symptoms (EPS) like tremors, stiffness, and restlessness (akathisia).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Haloperidol 1.5 mg requires strict quality controls:

  • Low-Dose Uniformity: Achieving precise content uniformity for 1.5 mg of API in a tablet is a technical challenge. As a WHO-GMP manufacturer, we utilize validated geometric dilution and specialized blending to ensure every tablet contains the exact therapeutic dose.

  • Stability for Export: Haloperidol is sensitive to light. We utilize opaque PVC/PVDC or Alu-Alu blister packaging to protect the tablets and ensure a 36-month shelf life during export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • Geriatric Considerations: The 1.5 mg strength is frequently used in elderly patients (starting at 0.5 mg to 2 mg). As a firm owner, you know the FDA “Black Box Warning” regarding increased mortality in elderly patients with dementia-related psychosis is a critical regulatory inclusion for your dossiers.

  • B2B & Dossier Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data against the innovator (Haldol) to support our B2B partners in international registration and hospital tender participation.

Haloperidol Tablets

Add to cart